Somatostatinrezeptor-PET/CT Journal Article


Authors: Boy, C.; Poeppel, T.; Kotzerke, J.; Krause, B. J.; Amthauer, H.; Baum, R. P.; Buchmann, I.; Ezziddin, S.; Führer, D.; Gabriel, M.; Kuwert, T.; Lahner, H.; Lauenstein, T.; Maecke, H. R.; Nagarajah, J.; Rösch, F.; Scheidhauer, K.; Schmidt, M.; Walter, M. A.; Bockisch, A.
Article Title: Somatostatinrezeptor-PET/CT
Abstract: Summary The present guideline is focused on quality assurance of somatostatin receptor PET/CT (SSTR-PET/CT) in oncology patients. The document has been developed by a multidisciplinary board of specialists providing consensus of definitions, prerequisites, methodology, operating procedures, assessment, and standardized reporting. In particular, imaging procedures for the two most commonly used radioligands of human SSTR, i. e. 68Ga-DOTATOC and 68Ga-DOTATATE are presented. Overall, SSTR-PET/CT requires close interdisciplinary communication and cooperation of referring and executing medical disciplines, taking into account existing guidelines and recommendations of the European and German medical societies, including the European Association of Nuclear Medicine (EANM), German Society for Endocrinology (DGE), German Society for Nuclear Medicine (DGN) and German Society for Radiology (DRG).
Keywords: cancer patient; practice guideline; somatostatin receptor; human; article; positron emission tomography-computed tomography; gallium dotatate ga 68; somatostatin receptor pet/ct (sstr-pet/ct); edotreotide ga 68
Journal Title: Nuklearmedizin
Volume: 57
Issue: 1
ISSN: 0029-5566
Publisher: Schattauer Gmbh  
Date Published: 2018-02-01
Start Page: 4
End Page: 17
Language: German; English
DOI: 10.1055/s-0038-1636560
PROVIDER: scopus
PUBMED: 29536494
DOI/URL:
Notes: "Somatostatin receptor PET/CT (SSTR-PET/CT)" -- Article -- Export Date: 2 April 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors